Berkshire Hathaway Just Repurchased Stock for the First Time Since 2024 -- It's a Green Light for Shareholders

Berkshire Hathaway has restarted its share buyback program (first restart since 2024), a positive signal that management views the stock as undervalued; the company repurchased about $9B in 2023, ~$3B in 2024 and none in 2025, versus roughly $60B of buybacks during 2020–2022. BRK.B's price-to-tangible-book has dropped below its five-year average, increasing the likelihood of further repurchases and supporting book value per share. This is a company-specific, bullish catalyst likely to lift Berkshire shares modestly but with limited broader market impact.

Analysis

Management choosing to redeploy capital into shares rather than M&A or new businesses is an allocation signal with measurable mechanical effects: fewer shares outstanding will lift per‑share book metrics and compress share supply for passive and quant strategies that rebalance to tangible‑book or dividend‑yield screens. That supply shock is most acute for liquid BRK.B, where buybacks can move dealer inventories and push implied volatility wider in the short end of the options curve, creating asymmetric hedging costs for large holders.

The competitive ripple isn’t limited to direct Berkshire peers: private equity and insurers that compete for large float investment will see the marginal dollar stay inside the parent if buybacks scale, reducing near‑term deal flow and M&A auction competition. Conversely, high‑growth, multiple‑expansion names become the principal alternate destination for incremental risk capital; expect flows to rotate into high‑momentum tech (amplifying names like NVDA) when repurchases pause and back into value when they accelerate.

Key risks are timing and scale mismatch: buybacks are a multi‑quarter lever — meaningful NAV lift requires sustained repurchase cadence (3–12 months) and is vulnerable to market rallies that erase the valuation gap or to insurance underwriting losses that force redeployment back into reserves. Watch three catalysts that would reverse the move: a sustained >10% rally in market cyclicals, a material increase in float‑related liabilities, or management commentary pivoting back to M&A — any of which can quickly unwind the valuation argument.

Key Decisions for Investors

• Long BRK.B (BRKB) equity, target +20% in 6–12 months, stop at -12% — rationale: capture mechanical EPS/book lift and reduced float premium; position size 3–5% notional to respect event risk.
• Pair trade: Long BRKB / Short NVDA, 1:0.25 notional, 3–9 month horizon — expected to outperform if capital rotates into buyback beneficiaries; target pair spread tightening 12–15% (BRKB outperformance), max drawdown 8% on the pair if NVDA keeps rallying.
• Options collar to express convexity: Buy BRKB Jan‑2027 1x call spread (buy nearer‑ATM, sell higher strike) financed by selling BRKB 3–6 month OTM puts — captures long skew for medium horizon while collecting premium; risk: put assignment requiring cash or liquidation if BRKB gaps down >15%.
• Event hedge: Buy protection on BRK insurance exposure via long-dated S&P put (or cash hedge) sized to cover 30–50% of position if underwriting stress emerges within 3–9 months — cost justified if buyback cadence accelerates but underwriting volatility remains the wildcard.